Yi-Zhen Yang

No ORCID on file · 4 papers in corpus
lab-animal 2024
Advanced oxidation protein products attenuate the autophagy-lysosome pathway in ovarian granulosa cells by modulating the ROS-dependent mTOR-TFEB pathway
Cell death & disease ·doi:10.1038/s41419-024-06540-w

Oxidative stress dysfunction has recently been found to be involved in the pathogenesis of premature ovarian insufficiency (POI). Previously, we found that advanced oxidation protein products (AOPPs) in plasma were elevated in women with PO…

observational 2023
Elevated cell-free mitochondria DNA level of patients with premature ovarian insufficiency
BMC pregnancy and childbirth ·doi:10.1186/s12884-023-05769-1

BACKGROUND: Premature ovarian insufficiency (POI) patients present with a chronic inflammatory state. Cell-free mitochondria DNA (cf-mtDNA) has been explored as a reliable biomarker for estimating the inflammation-related disorders, however…

observational 2023
Plasma metabolomic characterization of premature ovarian insufficiency
Journal of ovarian research ·doi:10.1186/s13048-022-01085-y

BACKGROUND: Premature ovarian insufficiency (POI) patients are predisposed to metabolic disturbances, including in lipid metabolism and glucose metabolism, and metabolic disorders appear to be a prerequisite of the typical long-term complic…

lab-animal 2021
Advanced Oxidation Protein Products Induce G1/G0-Phase Arrest in Ovarian Granulosa Cells via the ROS-JNK/p38 MAPK-p21 Pathway in Premature Ovarian Insufficiency
Oxidative medicine and cellular longevity ·doi:10.1155/2021/6634718

The mechanism underlying the role of oxidative stress and advanced oxidation protein products (AOPPs) in the aetiology of premature ovarian insufficiency (POI) is poorly understood. Here, we investigated the plasma AOPP level in POI patient…